Clinical Trials Logo

Cabazitaxel clinical trials

View clinical trials related to Cabazitaxel.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT02362620 Active, not recruiting - Clinical trials for Advanced Prostate Cancer

PROSTAC: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Docetaxel or Cabazitaxel.

PROSTAC
Start date: May 2014
Phase:
Study type: Observational

PROSTAC is a prospective multicentre observational study in metastatic Castration-Resistant Prostate Cancer (mCRPC), designed to explore prognostic biomarkers in patients undergoing treatment with docetaxel or cabazitaxel